Cite
MLA Citation
J. Datta et al.. “Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship.” HPB, vol. 21, n.d., pp. S58–S59. http://access.bl.uk/ark:/81055/vdc_100086213727.0x000020